Yoshida Daisuke, Ikeda Shota, Shinohara Keisuke, Kazurayama Masaya, Tanaka Shinji, Yamaizumi Masamitsu, Nagayoshi Hirokazu, Toyama Kensuke, Kinugawa Shintaro
Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Cardiovascular Center, Steel Memorial Yawata Hospital, Fukuoka, Japan.
J Gen Intern Med. 2024 Dec;39(16):3225-3233. doi: 10.1007/s11606-024-08809-4. Epub 2024 May 23.
The triglyceride-glucose index (TyG index), calculated as the logarithmic product of fasting triglyceride and glucose concentrations, is recognized as a simple marker of insulin resistance. However, the association between the TyG index and future decline of renal function remains unclear in the general population.
To investigate whether the TyG index was associated with future decline of renal function in the general population who had not progressed to chronic kidney disease stage G2.
Retrospective longitudinal observational cohort study.
Individuals who received a population-based health checkup at JA Ehime Kouseiren Checkup Center from 2010 to 2019 (n = 134,007). Individuals without data of baseline fasting triglyceride or glucose levels, or baseline and follow-up data of estimated glomerular filtration rate (eGFR), or those with baseline eGFR < 60 mL/min/1.73 m were excluded.
Future renal function decline, defined as a ≥ 25% decrease in eGFR from baseline.
Of 10,758 participants, 8,076 were classified into the low TyG index group (TyG index < 8.76, 1st to 3rd quartiles) and 2,682 into the high TyG index group (TyG index ≥ 8.76, 4th quartile). The mean follow-up period was 37.8 ± 23.6 months. The incidence rates of renal function decline were 0.31 and 0.69 per 100 person-years in the low and high TyG index groups, respectively. In multivariate Cox proportional hazard models, high TyG index was significantly associated with future renal function decline (hazard ratio 2.25, 95% CI 1.40-3.60). This association was consistent across subgroups stratified by age, sex, body mass index, baseline eGFR, and diagnosed hypertension, diabetes, or dyslipidemia.
In the general population, high TyG index was associated with future renal function decline. The TyG index may be useful in identifying individuals at high risk for future renal function decline in the setting of health checkups.
甘油三酯-葡萄糖指数(TyG指数),计算为空腹甘油三酯和葡萄糖浓度的对数乘积,被认为是胰岛素抵抗的一个简单标志物。然而,在一般人群中,TyG指数与未来肾功能下降之间的关联仍不明确。
调查TyG指数是否与尚未进展到慢性肾脏病G2期的一般人群未来肾功能下降有关。
回顾性纵向观察队列研究。
2010年至2019年在JA爱媛厚生连体检中心接受基于人群的健康检查的个体(n = 134,007)。排除没有基线空腹甘油三酯或葡萄糖水平数据、或估计肾小球滤过率(eGFR)的基线和随访数据的个体,或基线eGFR < 60 mL/min/1.73 m²的个体。
未来肾功能下降,定义为eGFR较基线下降≥25%。
在10,758名参与者中,8,076人被分类为低TyG指数组(TyG指数< 8.76,第1至第3四分位数),2,682人被分类为高TyG指数组(TyG指数≥8.76,第4四分位数)。平均随访期为37.8±23.6个月。低TyG指数组和高TyG指数组的肾功能下降发病率分别为每100人年0.31和0.69。在多变量Cox比例风险模型中,高TyG指数与未来肾功能下降显著相关(风险比2.25,95%CI 1.40 - 3.60)。这种关联在按年龄、性别、体重指数、基线eGFR以及是否诊断为高血压、糖尿病或血脂异常分层的亚组中是一致的。
在一般人群中,高TyG指数与未来肾功能下降有关。TyG指数可能有助于在健康检查中识别未来肾功能下降高风险个体。